Compugen (CGEN) Total Non-Current Liabilities (2009 - 2026)
Compugen recorded quarterly Total Non-Current Liabilities of $28.5 million in Q1 2026, down 8.95% quarter-over-quarter from $31.3 million in Q4 2025.
Compugen's Total Non-Current Liabilities history runs 11 years deep, the most recent figure standing at $28.5 million for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities changed N/A year-over-year to $28.5 million; the TTM figure through Mar 2026 stood at $28.5 million (changed N/A YoY), while the FY2025 annual figure was $31.3 million, down 21.67% from the prior year.
- Total Non-Current Liabilities came in at $28.5 million for Q1 2026 at Compugen, down from $31.3 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $39.9 million in Q4 2024 to a low of $4.6 million in Q4 2022.
- A 5-year average of $26.7 million and a median of $29.5 million in 2023 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities slumped 45.34% in 2022 and jumped 544.72% in 2023, its largest moves.
- Compugen's Total Non-Current Liabilities stood at $4.6 million in 2022, then surged by 544.72% to $29.5 million in 2023, then jumped by 35.28% to $39.9 million in 2024, then slipped by 21.67% to $31.3 million in 2025, then decreased by 8.95% to $28.5 million in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $28.5 million, $31.3 million, and $39.9 million for Q1 2026, Q4 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 11.03 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 42,980.09 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 95.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 110.28 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 5.87 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 7.32 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.05 Bn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 | 28.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.47 Mn |
| Dec 31, 2025 | 31.27 Mn |
| Sep 30, 2025 | 33.74 Mn |
| Jun 30, 2025 | 35.69 Mn |
| Mar 31, 2025 | 37.34 Mn |
| Dec 31, 2024 | 39.92 Mn |
| Sep 30, 2024 | 35.27 Mn |
| Jun 30, 2024 | 27.06 Mn |
| Mar 31, 2024 | 29.40 Mn |
| Dec 31, 2023 | 29.51 Mn |
| Sep 30, 2023 | 4.01 Mn |
| Jun 30, 2023 | 4.25 Mn |
| Mar 31, 2023 | 4.39 Mn |
| Dec 31, 2022 | 4.58 Mn |
| Sep 30, 2022 | 4.78 Mn |
| Jun 30, 2022 | 5.94 Mn |
| Mar 31, 2022 | 7.08 Mn |
| Dec 31, 2021 | 8.37 Mn |
| Sep 30, 2021 | 7.22 Mn |
| Jun 30, 2021 | 7.55 Mn |
| Mar 31, 2021 | 7.74 Mn |
| Dec 31, 2020 | 8.01 Mn |
| Sep 30, 2020 | 8.20 Mn |
| Jun 30, 2020 | 8.39 Mn |
| Mar 31, 2020 | 8.33 Mn |
| Dec 31, 2019 | 8.62 Mn |
| Sep 30, 2019 | 8.74 Mn |
| Jun 30, 2019 | 9.45 Mn |
| Mar 31, 2019 | 9.84 Mn |
| Dec 31, 2018 | 5.95 Mn |
| Sep 30, 2018 | 3.20 Mn |
| Jun 30, 2018 | 2.99 Mn |
| Mar 31, 2018 | 3.16 Mn |
| Dec 31, 2017 | 3.26 Mn |
| Sep 30, 2017 | 3.24 Mn |
| Jun 30, 2017 | 3.33 Mn |
| Mar 31, 2017 | 3.16 Mn |
| Dec 31, 2016 | 2.88 Mn |
| Sep 30, 2016 | 2.90 Mn |
| Jun 30, 2016 | 2.79 Mn |
| Mar 31, 2016 | 2.74 Mn |
| Dec 31, 2015 | 2.56 Mn |
| Sep 30, 2015 | 2.52 Mn |
| Jun 30, 2015 | 2.59 Mn |
| Mar 31, 2015 | 2.29 Mn |
| Dec 31, 2014 | 2.28 Mn |
| Sep 30, 2014 | 3.21 Mn |
| Jun 30, 2014 | 16.60 Mn |
| Mar 31, 2014 | 17.42 Mn |
| Dec 31, 2013 | 17.08 Mn |
| Sep 30, 2013 | 19.15 Mn |
| Jun 30, 2013 | 14.22 Mn |
| Mar 31, 2013 | 10.10 Mn |
| Dec 31, 2012 | 9.85 Mn |
| Sep 30, 2012 | 7.62 Mn |
| Jun 30, 2012 | 6.56 Mn |
| Mar 31, 2012 | 9.15 Mn |
| Dec 31, 2011 | 8.08 Mn |
| Sep 30, 2011 | 4.94 Mn |
| Jun 30, 2011 | 5.11 Mn |
| Mar 31, 2011 | 5.91 Mn |
| Dec 31, 2010 | 5.73 Mn |
| Sep 30, 2010 | 1.60 Mn |
| Dec 31, 2009 | 1.32 Mn |